Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional ...
Q3 2025 Earnings Call November 5, 2025 5:00 PM ESTCompany ParticipantsRobert Lahey - Head of Investor RelationsRaj Talluri ...
Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by ...
From adaptive brain stimulators to self-monitoring orthopedic implants, researchers are building intelligent medical devices that sense, decide, and treat, closing the loop between diagnosis and ...
Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant ...
Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
This guide describes how to move highlighted cells in Excel in Windows 11/10 using drag and drop, cut and paste, and other ...
Short ultraviolet/ozone (UVO) treatment optimizes cell adhesion on plastic culture substrates by selectively enriching ...
Every cell in the body has the same DNA, but different cell types—such as muscle or brain cells—use different parts of it.
The development of a new electromagnetic system could improve research and clinical capabilities through precise cell levitation.